Key Takeaways
-
Ocumetics has completed key manufacturing and clinical preparation milestones ahead of Group Two first-in-human IOL implantations in Mexico City
-
Group Two will assess lens safety and near- and distance-vision performance, expanding on the safety-focused Group One evaluation
-
Initial Group Two results are anticipated by year-end, while 12-month Group One follow-up findings are expected to be released shortly
Ocumetics Technology announced the completion of clinical, regulatory, and manufacturing milestones as it prepares to begin Group Two implantations in its first-in-human early feasibility study of the Ocumetics accommodating IOL.
The upcoming procedures, planned at a clinical site in Mexico City, will evaluate the safety and near- and distance-vision performance of the investigational lens. Unlike Group One, which focused primarily on safety, Group Two will assess the lens's visual performance and accommodative capabilities.
Ocumetics reported completing manufacturing and testing of its redesigned IOL, which incorporates engineering modifications intended to improve accommodative performance, surgical handling, reliability, and manufacturing scalability.
According to Ocumetics, the company has also confirmed the Mexico City clinical site, delivered redesigned lens delivery systems, submitted enhanced Group Two clinical protocols to the clinic's ethics committee, and initiated patient recruitment.
Remaining activities include final site initiation and surgeon training before implantation, followed by daily, weekly, and monthly patient monitoring.
Ocumetics has also begun evaluating 12-month follow-up results from Group One and expects to release those findings shortly.
“On the premise that Group Two patient results meet or exceed our objectives, as did Group One patient results, our prior discussions with several of the world’s largest ophthalmic companies can move to the next stage," said Dean Burns, CEO of Ocumetics. "We anticipate initial patient results will be in hand by the end of the year and data necessary to advance potential negotiations with the dominant ophthalmic companies will be available very early in the new year."
The Ocumetics Lens is designed to fit within the eye's natural lens compartment and use the eye's natural muscle activity to shift focus between near and distant objects.